Project Grant W911NF2510251
- The U.S. Defense Health Agency awarded a $718,032 Project Grant to the Scripps Research Institute in La Jolla, CA under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2025, targets the glycoimmune checkpoints Siglec-7 and -9 for the treatment of colorectal cancer. The project aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical research to develop innovative medical...
- This federal Project Grant award of $524,400.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research at the Scripps Research Institute in La Jolla, CA to develop novel chemical transformations and catalysts that enable the efficient synthesis of structurally complex small molecules for drug discovery. The research aims to address challenges in organic synthesis by...
- This federal Project Grant award for $874,000.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research on enantioselective and site-selective C-H activation reactions. The key objectives are to develop next-generation ligands capable of enantio- and site-selective C(SP3)-H activation of aliphatic carboxylic acid substrates, as well as to achieve enantio- and site-selective ring...
- The Scripps Research Institute was awarded a $404,450 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant, awarded on August 11, 2025, supports a two-year program to train a cohort of elite Scripps Research students in specialized translational chemical biology skills. The program aims to equip these students with advanced chemical biology and drug discovery capabilities to transition...
- The Project Grant award of $1,104,000.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides funding to the Scripps Research Institute in La Jolla, CA to conduct research on "TUMOR-TARGETED NANOCARRIERS FOR EFFECTIVE IMMUNOMODULATION OF OVARIAN CANCER." The award period runs from May 1, 2025 to April 30, 2028. This research aims to develop innovative, tumor-targeted nanocarrier technologies to enhance immunotherapeutic...
- The Department of Defense, through its Basic Scientific Research program (CFDA 12.431), awarded a $160,459.71 project grant to the University of Chicago to conduct tRNA sequencing research to examine the relationships of multiple branches of life. The award period runs from July 1, 2025 to June 30, 2028. The project aims to generate innovative scientific discoveries and technological capabilities that could potentially address long-term national security challenges and enhance military...
- This federal Project Grant award of $1,638,033, provided by the National Institutes of Health (NIH) under the Biomedical Research and Research Training Program (CFDA 93.859), supports the development of a CRISPR-free mammalian recombineering system at the Scripps Research Institute. The project aims to characterize and optimize a bacterial recombinase system for efficiently conducting large-scale DNA insertions, deletions, and substitutions in mammalian cells without inducing cytotoxic...
- This Project Grant award of $288,107 from the National Institute on Drug Abuse (NIDA), which falls under CFDA 93.279 Drug Use and Addiction Research Programs, aims to develop a new generation of leaders in addiction research. The key products or services to be provided under this grant include: Establishing a predoctoral training program at the Scripps Research Institute to equip young scientists with technical skills and expertise in transdisciplinary "team science" needed to...
- This $417,984 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research on pharmacological modulation of regulatory T cells. The project aims to: Identify the target and mechanism of action for a novel small molecule compound (A205804) that induces functional regulatory T cell differentiation in human and mouse cells. Optimize the pharmacokinetic properties of...
- The Scripps Research Institute received a $582,422 Project Grant from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), to accelerate discovery by merging kinetics with data science methods in catalytic organic reactions. The project aims to advance the Blackmond Laboratory's pioneering work in kinetic-assisted mechanistic analysis of organic catalytic reactions, leveraging reaction progress kinetic analysis...
The U.S. Department of Defense awarded a $199,999 Project Grant to the Scripps Research Institute under the Basic Scientific Research program (CFDA 12.431) to develop "genetically encoded, new-to-nature ligands with designer bioactivities." The grant supports fundamental research aimed at expanding scientific knowledge and understanding in areas critical to national security, such as biotechnology and advanced materials. Scripps Research Institute, a leading nonprofit biomedical research organization, will leverage its expertise in chemistry, biology, and computational science to pursue high-risk, high-payoff ideas that could lead to innovative scientific discoveries and technological capabilities. The grant has an award date of August 15, 2025, and an ultimate completion date of August 14, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $200.0k | 8/5/25 |